Grønningsæter SR, Blakkisrud J, Kvassheim M, Westrøm S, Aksnes AK, Løndalen A, Revheim ME, Bruland ØS, Mikalsen LTG, Wang Y, Larsen SG, Stokke C(2026) Normal Tissue Dosimetry of Intraperitoneal 224Ra Microparticle Therapy: Data from First-in-Human Studies in Patients with Peritoneal Metastases J Nucl Med(in press) DOI 10.2967/jnumed.125.271925, PubMed 42562608
Casali PG, Antoine-Poirel H, Berrocoso S, Blay JY, Dubois T, Ferrari A, Fullaondo A, Hovig E, Jagodzińska-Mucha P, Ługowska I, Kaasa S, Nicoară D, Pletsa V, Provenzano S, Santoro M, Šekerija M, Van Hoof W, Vyas M, Trama A, JANE Consortium(2026) Corrigendum to 'Health networking on cancer in the European Union: a 'green paper' by the EU Joint Action on Networks of Expertise (JANE)': [ESMO Open. Volume 10, Issue 2, February 2025, 104126] ESMO Open, 11(9), 108358(in press) DOI 10.1016/j.esmoop.2026.108358, PubMed 42556247
Vitolo U, Falchi L, Andersson PO, Nijland M, Offner F, Snauwaert S, Christensen JH, Clausen MR, Fosså A, Prieto PG, Hawkes EA, Jørgensen JM, Karimi YH, Lewerin C, Vermaat JSP, Wahlin BE, Patah P, Morehouse C, Risum M, Li Z, Marek J, Brody JD(2026) First-line treatment with epcoritamab in combination with bendamustine plus rituximab induces sustained remissions beyond 3 years in patients with follicular lymphoma Hemasphere, 10(8), e70443 DOI 10.1002/hem3.70443, PubMed 42553584
